Disruption of secreted cytokines in serum and peritoneal fluid of ovarian cancer patients may lead to their pro-inflammatory activation, indicating that modulation of cytokines of the IL-1 family may affect the course of the inflammatory process that accompanies the development of cancer. This evidence concerns the gene IL1B and ovarian carcinoma.